Tracking local breast cancer recurrence after surgery
Part of Cancer, Skin clinical trials.
This study follows people who have had breast cancer come back in the same area after their first surgery. It aims to learn more about local recurrence to improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had breast cancer surgery before (lumpectomy or mastectomy) and the cancer was invasive or ductal carcinoma in situ (DCIS).
- The cancer has come back in the same area (chest, breast, or scar) but has not spread to other organs.
- You are 18 years or older and able to care for yourself (ECOG 0-1).
- You are healthy enough to have another surgery and receive anti-cancer treatment.
- You are willing to participate and sign a consent form, and can attend follow-up visits as needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well “salvage” treatments work for breast cancer that has come back only in the local area (like the chest wall or nearby lymph nodes), without spreading to distant organs. It also tracks side effects to better understand the risks and benefits for patients who need additional treatment.
This Phase 2 study tests whether giving targeted radiation again to the same breast can control a small, local breast cancer that came back after prior whole-breast radiation. It may help some patients avoid or delay further treatment for the breast while carefully checking safety.
This trial uses a special light and dye to help surgeons find and remove lymph nodes that might contain cancer cells, in women whose breast cancer has come back in the same area after previous surgery.
This study tests local and regional radiation treatment after nipple-sparing mastectomy done with an implant. It may help reduce cancer returning in the breast/nearby tissues for people whose cancer hasn’t spread to distant sites.
This trial compares standard follow-up visits versus more intensive follow-up for people with early breast cancer after their main treatment. The goal is to see whether closer monitoring finds problems earlier or improves outcomes.
This study tests a local (targeted) approach for breast cancer that has spread to the liver. It looks at whether treating liver metastases with planned liver surgery, along with standard cancer treatment before and after, can improve outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.